Selected Publications


Wagner AH, Walsh B, Mayfield G, Tamborero D, Sonkin D, Krysiak K, Deu-Pons J, Duren RP, Gao J, McMurry J, Patterson S, Del Vecchio Fitz C, Pitel BA, Sezerman OU, Ellrott K, Warner JL, Rieke DT, Aittokallio T, Cerami E, Ritter DI, Schriml LM, Freimuth RR, Haendel M, Raca G, Madhavan S, Baudis M, Beckmann JS, Dienstmann R, Chakravarty D, Li XS, Mockus S, Elemento O, Schultz N, Lopez-Bigas N, Lawler M, Goecks J, Griffith M+, Griffith OL+, Margolin AA; Variant Interpretation for Cancer Consortium. A harmonized meta-knowledgebase of clinical interpretations of somatic genomic variants in cancer. Nat Genet. 2020 Apr;52(4):448-457.
pmid: 32246132; doi: 10.1038/s41588-020-0603-8

Wagner AH, Kiwala S, Coffman AC, McMichael JF, Cotto KC, Mooney TB, Barnell EK, Krysiak K, Danos AM, Walker J, Griffith M+, Griffith OL+. CIViCpy: A Python Software Development and Analysis Toolkit for the CIViC Knowledgebase. JCO CCI. 2020 Mar 19; 4, 245-253.
pmid: 32191543; doi: 10.1200/CCI.19.00127

Hundal J, Kiwala S, McMichael J, Miller CA, Xia H, Wollam AT, Liu CJ, Zhao S, Feng YY, Graubert AP, Wollam AZ, Neichin J, Neveau M, Walker J, Gillanders WE, Mardis ER, Griffith OL+, Griffith M+. pVACtools: A Computational Toolkit to Identify and Visualize Cancer Neoantigens. Cancer Immunol Res. 2020 Mar;8(3):409-420.
pmid: 31907209; doi: 10.1158/2326-6066.CIR-19-0401

Chu S, Wylie TN, Wylie KM, Johnson GC, Skidmore ZL, Fleer M, Griffith OL, Bryan JN. A virome sequencing approach to feline oral squamous cell carcinoma to evaluate viral causative factors. Vet Microbiol.
pmid: 31902496; doi: 10.1016/j.vetmic.2019.108491


Lever J, Jones MR, Danos AM, Krysiak K, Bonakdar M, Grewal JK, Culibrk L, Griffith OL+, Griffith M+, Jones SJM+. Text-mining clinically relevant cancer biomarkers for curation into the CIViC database. Genome Med. 2019 Dec 03;11(1):78.
pmid: 31796060; doi: 10.1186/s13073-019-0686-y

Danos AM, Krysiak K, Barnell EK, Coffman AC, McMichael JF, Kiwala S, Spies NC, Sheta LM, Pema SP, Kujan L, Clark KA, Wollam AZ, Rao S, Ritter DI, Sonkin Dmitriy, Raca G, Lin W, Grisdale CJ, Kim RH, Wagner AH, Madhavan S, Griffith M+, Griffith OL+. Standard operating procedure for curation and clinical interpretation of variants in cancer. Genome Med. 2019 Nov 29;11, 76.
pmid: 31779674; doi: 10.1186/s13073-019-0687-x

Barnell EK, Waalkes A, Mosior MC, Penewit K, Cotto KC, Danos AM, Sheta LM, Campbell KM, Krysiak K, Rieke D, Spies NC, Skidmore ZL, Pritchard CC, Fehniger TA, Uppaluri R, Govindan R, Griffith M+, Salipante SJ+, Griffith OL+. Open-Sourced CIViC Annotation Pipeline to Identify and Annotate Clinically Relevant Variants Using Single-Molecule Molecular Inversion Probes. JCO CCI. 2019 Oct 16;3, 1-12.
pmid: 31618044; doi: 10.1200/CCI.19.00077

Richters MM, Xia H, Campbell KM, Gillanders WE, Griffith OL+, Griffith M+. Best practices for bioinformatic characterization of neoantigens for clinical utility. Genome Med. 2019 Aug 28;11(1):56.
pmid: 31462330; doi: 10.1186/s13073-019-0666-2

Campbell KM, O'Leary KA, Rugowski DE, Mulligan WA, Barnell EK, Skidmore ZL, Krysiak K, Griffith M, Schuler LA+, Griffith OL+. A Spontaneous Aggressive ERα+ Mammary Tumor Model Is Driven by Kras Activation. Cell Rep. 2019 Aug 6;28(6):1526-1537.e4.
pmid: 31390566; doi: 10.1016/j.celrep.2019.06.098

Barnell E, Kang Y, Wurtzler E, Griffith M, Chaudhuri AA+, Griffith OL+; Geneoscopy Scientists. Noninvasive Detection of High-Risk Adenomas Using Stool-Derived Eukaryotic RNA Sequences as Biomarkers. Gastroenterology. 2019 May 30. pii: S0016-5085(19)40976-1. [Epub ahead of print].
pmid: 31154021; doi: 10.1053/j.gastro.2019.05.058

Barnell EK, Ronning P, Campbell KM, Krysiak K, Ainscough BJ, Sheta LM, Pema SP, Schmidt AD, Richters M, Cotto KC, Danos AM, Ramirez C, Skidmore ZL, Spies NC, Hundal J, Sediqzad MS, Kunisaki J, Gomez F, Trani L, Matlock M, Wagner AH, Swamidass SJ, Griffith M+, Griffith OL+. Standard operating procedure for somatic variant refinement of sequencing data with paired tumor and normal samples. Genet Med. 2019 Apr;21(4):972-981.
pmid: 30287923; doi: 10.1038/s41436-018-0278-z

Hundal J, Kiwala S, Feng YY, Liu CJ, Govindan R, Chapman WC, Uppaluri R, Swamidass SJ, Griffith OL, Mardis ER, Griffith M. Accounting for proximal variants improves neoantigen prediction. Nat Genet. 2019 Jan;51(1):175-179.
pmid: 30510237; doi: 10.1038/s41588-018-0283-9


Ainscough BJ*, Barnell EK*, Ronning P, Campbell KM, Wagner AH, Fehniger TA, Dunn GP, Uppaluri R, Govindan R, Rohan TE, Griffith M, Mardis ER, Swamidass SJ+, Griffith OL+. A deep learning approach to automate refinement of somatic variant calling from cancer sequencing data. Nat Genet. 2018 Dec;50(12):1735-1743.
pmid: 30397337; doi: 10.1038/s41588-018-0257-y

Danos AM, Ritter DI, Wagner AH, Krysiak K, Sonkin D, Micheel C, McCoy M, Rao S, Raca G, Boca SM, Roy A, Barnell EK, McMichael JF, Kiwala S, Coffman AC, Kujan L, Kulkarni S+, Griffith M+, Madhavan S+, Griffith OL+. Adapting crowdsourced clinical cancer curation in CIViC to the ClinGen minimum variant level data community-driven standards. Hum Mutat. 2018 Nov;39(11):1721-1732.
pmid: 30311370; doi: 10.1002/humu.23651

Wagner AH*, Devarakonda S*, Skidmore ZL, Krysiak K, Ramu A, Trani L, Kunisaki J, Masood A, Waqar SN, Spies NC, Morgensztern D, Waligorski J, Ponce J, Fulton RS, Maggi LB Jr, Weber JD, Watson MA, O'Conor CJ, Ritter JH, Olsen RR, Cheng H, Mukhopadhyay A, Can I, Cessna MH, Oliver TG, Mardis ER, Wilson RK, Griffith M+, Griffith OL+, Govindan R+. Recurrent WNT pathway alterations are frequent in relapsed small cell lung cancer. Nat Commun. 2018 Sep 17;9(1):3787.
pmid: 30224629; doi: 10.1038/s41467-018-06162-9

Griffith OL*, Spies NC*, Anurag M*, Griffith M, Luo J, Tu D, Yeo B, Kunisaki J, Miller CA, Krysiak K, Hundal J, Ainscough BJ, Skidmore ZL, Campbell K, Kumar R, Fronick C, Cook L, Snider JE, Davies S, Kavuri SM, Chang EC, Magrini V, Larson DE, Fulton RS, Liu S, Leung S, Voduc D, Bose R, Dowsett M, Wilson RK, Nielsen TO, Mardis ER+, Ellis MJ+. The prognostic effects of somatic mutations in ER-positive breast cancer. Nat Commun. 2018 Sep 4;9(1):3476.
pmid: 30181556; doi: 10.1038/s41467-018-05914-x

Campbell KM*, Lin T*, Zolkind P*, Barnell EK, Skidmore ZL, Winkler AE, Law JH, Mardis ER, Wartman LD, Adkins DR, Chernock RD, Griffith M, Uppaluri R+, Griffith OL+. Oral Cavity Squamous Cell Carcinoma Xenografts Retain Complex Genotypes and Intertumor Molecular Heterogeneity. Cell Rep. 2018 Aug 21;24(8):2167-2178.
pmid: 30134176; doi: 10.1016/j.celrep.2018.07.058

Miller CA, Tricarico C, Skidmore ZL, Uy GL, Lee YS, Hassan A, O'Laughlin MD, Schmidt H, Tian L, Duncavage EJ, Griffith M, Griffith OL, Welch JS, Wartman LD. A case of acute myeloid leukemia with promyelocytic features characterized by expression of a novel RARG-CPSF6 fusion. Blood Adv. 2018 Jun 12;2(11):1295-1299.
pmid: 29891591; doi: 10.1182/bloodadvances.2017014183

Madhavan S, Ritter D, Micheel C, Rao S, Roy A, Sonkin D, Mccoy M, Griffith M, Griffith OL, Mcgarvey P, Kulkarni S. Standardizing And Democratizing Access To Cancer Molecular Diagnostic Test Data From Patients To Drive Translational Research. AMIA Jt Summits Transl Sci Proc. 2018 May 18;2017:152-159. eCollection 2018.
pmid: 29888062;

Madhavan S, Ritter D, Micheel C, Rao S, Roy A, Sonkin D, Mccoy M, Griffith M, Griffith OL, Mcgarvey P, Kulkarni S. ClinGen Cancer Somatic Working Group - standardizing and democratizing access to cancer molecular diagnostic data to drive translational research. Pac Symp Biocomput. 2018;23:247-258.
pmid: 29218886; doi: 10.1142/9789813235533_0023

Cotto KC*, Wagner AH*+, Feng YY, Kiwala S, Coffman AC, Spies G, Wollam A, Spies NC, Griffith OL+, Griffith M+. DGIdb 3.0: a redesign and expansion of the drug-gene interaction database. Nucleic Acids Res. 2018 Jan 4;46(D1):D1068-D1073.
pmid: 29156001; doi: 10.1093/nar/gkx1143

Bartlett NL+, Costello BA, LaPlant BR, Ansell SM, Kuruvilla JG, Reeder CB, Thye LS, Anderson DM, Krysiak K, Ramirez C, Qi J, Siegel BA, Griffith M, Griffith OL, Gomez F*, Fehniger TA*. Single-Agent Ibrutinib in Relapsed or Refractory Follicular Lymphoma: A Phase 2 Consortium Trial. Blood. 2018 Jan 11;131(2):182-190.
pmid: 29074501; doi: 10.1182/blood-2017-09-804641


Ma CX, Suman V, Goetz MP, Northfelt DW, Burkard ME, Ademuyiwa F, Naughton MJ, Margenthaler J, Aft R, Gray RJ, Tevaarwerk AJ, Wilke LG, Haddad TC, Moynihan T, Loprenzi C, Hieken T, Barnell EK, Skidmore ZL, Feng YY, Krysiak K, Hoog J, Guo Z, Nehring L, Wisinski KB, Mardis ER, Hagemann IS, Vij K, Sanati S, Al-Kateb H, Griffith OL, Griffith M, Doyle A, Erlichman C, Ellis MJ. A Phase II trial of neoadjuvant MK2206, an AKT inhibitor, with anastrozole in clinical stage 2 or 3 PIK3CA mutant ER positive and HER2 negative breast cancer. Clin Cancer Res. 2017 Nov 15;23(22):6823-6832.
pmid: 28874413; doi: 10.1158/1078-0432.CCR-17-1260

Feng YY, Griffith OL+, Griffith M+. Clinical implications of neoepitope landscapes for adult and pediatric cancers. Genome Med. 2017 Aug 31;9(1):77.
pmid: 28854952; doi: 10.1186/s13073-017-0470-9

Ma CX, Gao F, Luo J, Northfelt DW, Goetz M, Forero A, Hoog J, Naughton M, Ademuyiwa F, Suresh R, Anderson KS, Margenthaler J, Aft R, Hobday T, Moynihan T, Gillanders W, Cyr A, Eberlein TJ, Hieken T, Krontiras H, Guo Z, Lee MV, Spies NC, Skidmore ZL, Griffith OL, Griffith M, Thomas S, Bumb C, Vij K, Bartlett CH, Koehler M, Al-Kateb H, Sanati S, Ellis MJ. NeoPalAna: Neoadjuvant Palbociclib, a Cyclin-Dependent Kinase 4/6 Inhibitor, and Anastrozole for Clinical Stage 2 or 3 Estrogen Receptor-Positive Breast Cancer. Clinical Cancer Research. 2017 Aug 1;23(15):4055-4065.
pmid: 28270497; doi: 10.1158/1078-0432.CCR-16-3206

Whyte MP, Griffith M, Trani L, Mumm S, Gottesman GS, McAlister WH, Krysiak K, Lesurf R, Skidmore ZL, Campbell KM, Rosman IS, Bayliss S, Bijanki VN, Nenninger A, Van Tine BA, Griffith OL, Mardis ER. Melorheostosis: Exome sequencing of an associated dermatosis implicates postzygotic mosaicism of mutated KRAS. Bone. 2017 Aug;101:145-155.
pmid: 28434888; doi: 10.1016/j.bone.2017.04.010

Lesurf R, Griffith OL, Griffith M, Hundal J, Trani L, Watson MA, Aft R, Ellis MJ, Ota D, Suman VJ, Meric-Bernstam F, Leitch AM, Boughey JC, Unzeitig G, Buzdar AU, Hunt KK, Mardis ER. Genomic characterization of HER2-positive breast cancer and response to neoadjuvant trastuzumab and chemotherapy-results from the ACOSOG Z1041 (Alliance) trial. Annals of Oncology. 2017 May 1;28(5):1070-1077.
pmid: 28453704; doi: 10.1093/annonc/mdx048

Griffith M*+, Spies NC*, Krysiak K*, McMichael JF, Coffman AC, Danos AM, Ainscough BJ, Ramirez CA, Rieke DT, Kujan L, Barnell EK, Wagner AH, Skidmore ZL, Wollam A, Liu CJ, Jones MR, Bilski RL, Lesurf R, Feng YY, Shah NM, Bonakdar M, Trani L, Matlock M, Ramu A, Campbell KM, Spies GC, Graubert AP, Gangavarapu K, Eldred JM, Larson DE, Walker JR, Good BM, Wu C, Su AI, Dienstmann R, Margolin AA, Tamborero D, Lopez-Bigas N, Jones SJ, Bose R, Spencer DH, Wartman LD, Wilson RK, Mardis ER, Griffith OL+. CIViC is a community knowledgebase for expert crowdsourcing the clinical interpretation of variants in cancer. Nature Genetics. 2017 Jan 31;49(2):170-174.
pmid: 28138153; doi: 10.1038/ng.3774

Krysiak K, Gomez F, White BS, Matlock M, Miller CA, Trani L, Fronick CC, Fulton RS, Kreisel F, Cashen AF, Carson KR, Berrien-Elliott MM, Bartlett NL, Griffith M+, Griffith OL+, Fehniger TA+. Recurrent somatic mutations affecting B-cell receptor signaling pathway genes in follicular lymphoma. Blood. 2017 Jan 26;129(4):473-483.
pmid: 28064239; doi: 10.1182/blood-2016-07-729954


Zolkind P, Dunn GP, Lin T, Griffith M, Griffith OL, Uppaluri R. Neoantigens in immunotherapy and personalized vaccines: Implications for head and neck squamous cell carcinoma. Oral Oncology. 2017 Aug;71:169-176.
pmid: 27751760; doi: 10.1016/j.oraloncology.2016.09.010

Fu X, Jeselsohn R, Pereira R, Hollingsworth EF, Creighton CJ, Li F, Shea M, Nardone A, De Angelis C, Heiser LM, Anur P, Wang N, Grasso CS, Spellman P, Griffith OL, Tsimelzon A, Gutierrez C, Huang S, Edwards DP, Trivedi MV, Rimawi MF, Lopez-Terrada D, Hilsenbeck SG, Gray JW, Brown M, Osborne CK, Schiff R. FOXA1 overexpression mediates endocrine resistance by altering the ER transcriptome and IL-8 expression in ER-positive breast cancer. Proceedings of the National Academy of Sciences. 2016 113(43):E6600-E6609.
pmid: 27791031; doi: 10.1073/pnas.1612835113

Skidmore ZL, Wagner AH, Lesurf R, Campbell KM, Kunisaki J, Griffith OL+, Griffith M+. GenVisR: Genomic Visualizations in R. Bioinformatics. 2016 Oct 1;32(19):3012-4.
pmid: 27288499; doi: 10.1093/bioinformatics/btw325

Xin J, Mark A, Afrasiabi1 C, Tsueng G, Juchler M, Gopal N, Stupp GS, Putman TE, Ainscough BJ, Griffith OL, Torkamani A, Whetzel PL, Mungall CJ, Mooney SD, Su AI, Wu C. and Gene and Variant Annotation Query Services. Genome Biology. 2016 17(1):91.
pmid: 27154141; doi: 10.1186/s13059-016-0953-9

Turpin J, Ling C, Crosby EJ, Hartman ZC, Simond AM, Chodosh LA, Rennhack JP, Andrechek ER, Ozcelik J, Hallett M, Mills GB, Cardiff RD, Gray JW, Griffith OL, Muller WJ. The ErbB2ΔEx16 splice variant is a major oncogenic driver in breast cancer that promotes a pro-metastatic tumor microenvironment. Oncogene. 2016 35(47):6053-6064.
pmid: 27157621; doi: 10.1038/onc.2016.129

Ainscough BJ, Griffith M+, Coffman AC, Wagner AH, Kunisaki J, Choudhary MN, McMichael JF, Fulton RS, Wilson RK, Griffith OL+, Mardis ER. DoCM: a database of curated mutations in cancer. Nature Methods. 2016 Sep 29;13(10):806-7.
pmid: 27684579; doi: 10.1038/nmeth.4000

Griffith OL*, Chan SR*, Griffith M, Krysiak K, Skidmore ZL, Hundal J, Allen JA, Arthur CD, Runci D, Bugatti M, Miceli AP, Schmidt H, Trani L, Kanchi KL, Miller CA, Larson DE, Fulton RS, Vermi W, Wilson RK, Schreiber RD+, Mardis ER+. Truncating Prolactin Receptor Mutations Promote Tumor Growth in Murine Estrogen Receptor-Alpha Mammary Carcinomas. Cell Reports. 2016 Sep 27;17(1):249-60.
pmid: 27681435; doi: 10.1016/j.celrep.2016.08.076

Miller CA, Gindin Y, Lu C, Griffith OL, Griffith M, Shen D, Hoog J, Li T, Larson DE, Watson M, Davies SR, Hunt K, Suman VJ, Snider J, Walsh T, Colditz GA, DeSchryver K, Wilson RK, Mardis ER, Ellis MJ. Aromatase inhibition remodels the clonal architecture of estrogen-receptor-positive breast cancers. Nature Communications. 2016 Aug 9;7:12498.
pmid: 27502118; doi: 10.1038/ncomms12498

Griffith M*+, Griffith OL*, Krysiak K, Skidmore ZL, Christopher MJ, Klco JM, Ramu A, Lamprecht TL, Wagner AH, Campbell KM, Lesurf R, Hundal J, Zhang J, Spies NC, Ainscough BJ, Larson DE, Heath SE, Fronick C, O'Laughlin S, Fulton R, Magrini V, McGrath S, Smith SM, Miller CA, Maher CA, Payton JE, Walker JR, Eldred JM, Walter MJ, Link DC, Graubert TA, Westervelt P, Kulkarni S, DiPersio JF, Mardis ER, Wilson RK, Ley TJ+. Comprehensive genomic analysis reveals FLT3 activation and a therapeutic strategy for a patient with relapsed adult B-lymphoblastic leukemia. Experimental Hematology. 2016 Jul;44(7):603-13.
pmid: 27181063; doi: 10.1016/j.exphem.2016.04.011

Krysiak K, Christopher MJ, Skidmore ZL, Demeter RT, Magrini V, Kunisaki J, O'Laughlin M, Duncavage EJ, Miller CA, Ozenberger BA, Griffith M, Wartman LD+, Griffith OL+. A genomic analysis of Philadelphia chromosome-negative AML arising in patients with CML. Blood Cancer Journal. 2016 Apr 8;6:e413.
pmid: 27058228; doi: 10.1038/bcj.2016.18


Ma CX, Luo J, Naughton M, Ademuyiwa FO, Suresh R, Griffith M, Griffith OL, Skidmore Z, Spies NC, Ramu A, Trani L, Pluard T, Nagaraj G, Thomas SN, Guo Z, Hoog J, Han J, Mardis ER, Lockhart AC, Ellis MJ. A phase 1 trial of BKM120 (Buparlisib) in combination with fulvestrant in postmenopausal women with estrogen receptor positive metastatic breast cancer. Clinical Cancer Research. 2015 Nov 12. pii: clincanres.1745.2015.
pmid: 26563128; doi: 10.1158/1078-0432.CCR-15-1745

Griffith OL*+, Griffith M*, Krysiak K*, Magrini V, Ramu A, Skidmore ZL, Kunisaki J, Austin R, McGrath S, Zhang J, Demeter R, Graves T, Eldred JM, Walker J, Larson DE, Maher CA, Lin Y, Chapman W, Mahadevan A, Miksad R, Nasser I, Hanto DW, Mardis ER. A genomic case study of mixed fibrolamellar hepatocellular carcinoma. Annals of Oncology. 2016 Mar 30. pii: mdw135.
pmid: 27029710; doi: 10.1093/annonc/mdw135

Hundal J, Carreno BM, Petti AA, Linette GP, Griffith OL, Mardis ER, Griffith M. pVAC-Seq: A genome-guided in silico approach to identifying tumor neoantigens. Genome Medicine. 2016 Jan 29;8(1):11.
pmid: 26825632; doi: 10.1186/s13073-016-0264-5

Lesurf R, Cotto KC, Wang G, Griffith M, Kasaian K, Jones SJ, Montgomery SB+, Griffith OL+; Open Regulatory Annotation Consortium. ORegAnno 3.0: a community-driven resource for curated regulatory annotation. Nucleic Acids Research. 2016 Jan 4;44(D1):D126-32.
pmid: 26578589; doi: 10.1093/nar/gkv1203

Wagner AH, Coffman AC, Ainscough BJ, Spies NC, Skidmore ZL, Campbell KM, Krysiak K, Pan D, McMichael JF, Eldred JM, Walker JR, Wilson RK, Mardis ER, Griffith M+, Griffith OL+. DGIdb 2.0: mining clinically relevant drug-gene interactions. Nucleic Acids Research. 2016 Jan 4;44(D1):D1036-44.
pmid: 26531824; doi: 10.1093/nar/gkv1165

Lu C, Riedell P, Miller CA, Hagemann IS, Westervelt P, Ozenberger BA, OLaughlin M, Magrini V, Demeter RT, Duncavage EJ, Griffith M, Griffith OL, Wartman LD. A common founding clone with TP53 and PTEN mutations gives rise to a concurrent germ cell tumor and acute megakaryoblastic leukemia. Cold Spring Harbor Molecular Case Studies. 2016 Jan;2(1):a000687.
pmid: 27148581; doi: 10.1101/mcs.a000687

Griffith M*, Miller CA*, Griffith OL, Krysiak KC, Skidmore ZL, Ramu A, Walker JR, Dang H, Trani L, Larson DE, Demeter RT, Wendl MC, McMichael JF, Austin R, Magrini V, McGrath S, Ly A, Kulkarni S, Cordes M, Fronick CC, Fulton RS, Maher CA, Ding L, Klco JM, Mardis ER, Ley TJ, Wilson RK. Optimizing cancer genome sequencing and analysis. Cell Systems. 2015 Sep 23;1(3):210-223.
pmid: 26645048; doi: 10.1016/j.cels.2015.08.015

Klco JM, Miller CA, Griffith M, Petti A, Spencer DH, Ketkar-Kulkarni S, Wartman LD, Christopher M, Lamprecht TL, Helton NM, Duncavage EJ, Payton JE, Baty J, Heath SE, Griffith OL, Shen D, Hundal J, Chang GS, Fulton R, O'Laughlin M, Fronick C, Magrini V, Demeter RT, Larson DE, Kulkarni S, Ozenberger BA, Welch JS, Walter MJ, Graubert TA, Westervelt P, Radich JP, Link DC, Mardis ER, DiPersio JF, Wilson RK, Ley TJ. Association Between Mutation Clearance After Induction Therapy and Outcomes in Acute Myeloid Leukemia. Journal of the American Medical Association. 2015 Aug 25;314(8):811-22.
pmid: 26305651; doi: 10.1001/jama.2015.9643

Griffith M, Walker JR, Spies NC, Ainscough BJ, Griffith OL. Informatics for RNA Sequencing: A Web Resource for Analysis on the Cloud. PLoS Computational Biology. 2015 Aug 6;11(8):e1004393.
pmid: 26248053; doi: 10.1371/journal.pcbi.1004393

Griffith M*, Griffith OL*, Smith SM*, Ramu A, Callaway MB, Brummett AM, Kiwala MJ, Coffman AC, Regier AA, Oberkfell BJ, Sanderson GE, Mooney TP, Nutter NG, Belter EA, Du F, Long RL, Abbott TE, Ferguson IT, Morton DL, Burnett MM, Weible JV, Peck JB, Dukes A, McMichael JF, Lolofie JT, Derickson BR, Hundal J, Skidmore ZL, Ainscough BJ, Dees ND, Schierding WS, Kandoth C, Kim KH, Lu C, Harris CC, Maher N, Maher CA, Magrini VJ, Abbott BS, Chen K, Clark E, Das I, Fan X, Hawkins AE, Hepler TG, Wylie TN, Leonard SM, Schroeder WE, Shi X, Carmichael LK, Weil MR, Wohlstadter RW, Stiehr G, McLellan MD, Pohl CS, Miller CA, Koboldt DC, Walker JR, Eldred JM, Larson DE, Dooling DJ, Ding L, Mardis ER, Wilson RK. Genome Modeling System: A Knowledge Management Platform for Genomics. PLoS Computational Biology. 2015 Jul 9;11(7):e1004274.
pmid: 26158448; doi: 10.1371/journal.pcbi.1004274

Complete Bibliography (PubMed)

Obi Griffith

Malachi Griffith